Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Role of Telehealth Technologies in the Creation of Smart Hospitals

Telehealth has been around for quite a while. However, it took the pandemic to generate widespread adoption and acceptance of telehealth in hospitals globally. In this episode of “Health and Life Sciences at the Edge,” host Justin Honore talks with Intel’s Ed Buffone about the technologies that are making Smart Hospitals a reality and the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Telehealth has been around for quite a while. However, it took the pandemic to generate widespread adoption and acceptance of telehealth in hospitals globally. In this episode of “Health and Life Sciences at the Edge,” host Justin Honore talks with Intel’s Ed Buffone about the technologies that are making Smart Hospitals a reality and the challenges that must still be addressed.

“During the pandemic, the healthcare system was under siege. This virus was draining the resources of every hospital in the country,” says Buffone. “We needed alternative ways to reach and treat patients. The two technologies that made that possible were virtual visits and remote monitoring.” However, telehealth encompasses a broad range of technologies and applications that must work seamlessly together to make Smart Hospitals viable. “What hospitals lack is an organized, holistic approach to telehealth,” says Buffone. “In many hospitals, individual departments deploy telehealth, but they’re siloed. The solution is a cohesive, enterprise-wide approach.”

The three major technologies driving the move to Smart Hospitals are Artificial Intelligence (AI), Analytics, and 5G. “AI is a key element that makes hospitals Smart Hospitals,” says Buffone. “Healthcare is an industry that is rich in data, and AI takes advantage of that data to give clinicians more insight into patient care.” Buffone refers to AI as Assisted rather than Artificial Intelligence. “When it comes to healthcare, there’s nothing artificial about AI,” he says. “The clinician is making the intelligent decisions for the patient. AI just provides data that can help.”

Working alongside AI are analytics and 5G. Analytics provide insights into patient populations and 5G extends patient care networks, making it possible to follow patients through their care journeys.

According to Buffone, there are three main hurdles to implementing these technologies in hospitals – finances, staffing, and lack of organization. “I think the real solution is maturity,” says Buffone. “Maturity of the technologies and the processes. As these technologies become more accepted and integrated into the workflow, the overall financial lift lessens. At that point everyone has a clear understanding of the return on investment and how the technologies provide for lower costs, most efficiency, and better patient satisfaction. Ultimately, that’s what we’re after,” Buffone adds. “It’s all about the patient journey, patient satisfaction, and patient safety. If you can do that while lowering costs and providing more operational efficiencies those barriers will fall away.”

Connect with Ed Buffone on LinkedIn. 

Follow us on Twitter: @IntelHealth 

To learn more about telehealth and Smart Hospitals visit: https://www.intel.com/content/www/us/en/healthcare-it/smart-hospital.html 

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Internet of Things Group. 

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512